PathAI
About PathAI
PathAI is a healthcare technology company that uses AI-powered pathology to improve patient outcomes. It develops and deploys digital pathology solutions and AI algorithms for pathology workflows, enabling biomarker discovery, drug development, and more efficient collaboration with biopharma, laboratories, and clinicians across global healthcare settings.
Recent News
Roche to Pay $750 Million Upfront for AI Diagnostics Pioneer PathAI
Pharma and Biotech M&As 2026 Deal Watcher
Roche to Acquire PathAI for up to $1 Billion, Expanding Digital Pathology Portfolio
FDA Approves Grifols Malaria Blood Screening Assay
Roche Signs Agreement to Acquire AI Pathology Leader PathAI
Vendor Notebook: AI Tackles an Evolving Menu of Organizational Needs
Roche to Acquire PathAI in Up‑to‑$1 B AI Cancer‑Diagnostics Deal
Roche to Acquire PathAI for Up to $1.05 B, Accelerating AI‑Driven Diagnostics
Fujifilm and mTuitive Link Structured Pathology Reporting to Enterprise Imaging in New Partnership
Omnia Inventa Introduces LNL300 for Lymph Node Retrieval
Latest TechBio News
Roche’s $1.05 B PathAI Deal Highlights Massachusetts AI Hub Momentum